Compare XLO & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XLO | CLPR |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.9M | 51.2M |
| IPO Year | 2021 | 2015 |
| Metric | XLO | CLPR |
|---|---|---|
| Price | $8.45 | $3.34 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | 13.5K | ★ 27.3K |
| Earning Date | 11-10-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 11.38% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $43,766,000.00 | ★ $109,997,000.00 |
| Revenue This Year | $3.55 | $0.91 |
| Revenue Next Year | $9.26 | $2.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 589.88 | 5.82 |
| 52 Week Low | $0.46 | $2.69 |
| 52 Week High | $22.60 | $3.92 |
| Indicator | XLO | CLPR |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 57.38 |
| Support Level | $7.29 | $3.09 |
| Resistance Level | $9.35 | $3.53 |
| Average True Range (ATR) | 0.67 | 0.17 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 58.97 | 68.75 |
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.